A. Li et al. / Tetrahedron: Asymmetry 14 (2003) 75–78
77
crude product was purified by column chromatography
3.6. (S)-(+)-ar-Turmerone, 2
to afford the alcohol 5 (1.85 g, 89%), [h]2D0 +14.6,
(c=5.0, CHCl3, e.e.>93%, lit.11 [h]D +14.01 (c 1.26,
To a solution of alcohol 1 and epi-1 (1.1 g, 5 mmol) in
carbon tetrachloride (20 mL) was added manganese
dioxide (4.4 g), the mixture was stirred at 60°C for 30
min and the oxidant was filtered off, the filtrate was
evaporated and the crude product was purified by
column chromatography to afford the ketone 2 (1.0 g,
94%), [h]2D0 +82.7 (c 6.8, CHCl3, lit.12 [h]D +81.56
1
CHCl3). H NMR l 1.208 (d, 3H, J=7.0 Hz), 2.303 (s,
3H), 2.790–2.894 (m, 1H), 3.565 (d, 2H, J=7.2 Hz),
7.096 (s, 4H). MS (EI): m/z 150, 119 and 91.
3.4. (R)-(+)-1-Bromo-2-(4-methylphenyl)propane, 6
1
To a solution of alcohol 5 (1.8 g, 12 mmol) together
with triphenyl phosphine (3.8 g, 14.5 mmol) in methyl-
ene dichloride 40 mL was added in portion carbon
tetrabromide (4.1 g, 12.4 mmol). After addition, the
solution was stirred at rt for 4 h, then petroleum ether
40 mL was added. The reaction mixture was filtered by
suction, and washed with petroleum ether: ethyl acetate
(10:1), the organic solution was evaporated and the
crude product was purified by column chromatography
to give the bromide 6 (2.52 g, 99%), [h]2D0 +24.2 (c 9.0,
(CHCl3). H NMR l 1.227 (d, 3H, J=7.0 Hz), 1.851
and 1.990 (s, each 3H), 2.306 (s, 3H), 2.540–2.776 (m,
2H), 3.244–3.351 (m, 1H), 6.026 (s, 1H), 7.104 (s, 4H).
13C NMR l 20.59, 20.87, 21.91, 27.49, 35.23, 52.62,
124.06, 126.59, 129.03, 135.42, 143.63, 154.84, 199.68.
MS (EI): m/z 216, 201, 132, 119, 83.
3.7. (7S,9R)-(+)-Bisacumol, 1
Under an atmosphere of Ar, to a solution of ketone 2
(430 mg, 2 mmol) and catalyst 8 (0.2 mmol) in toluene
(10 mL) was added dropwise catecholborane (1 M, 4
mL) at −78°C, the mixture was stirred at this tempera-
ture for 16 h, then quenched with water. The mixture
was allowed to warm to room temperature and stirred
for 30 min, after separation of the layer, the aqueous
phase was further extracted with ethyl acetate (3×50
mL). The combined organic extracts were washed suc-
cessively with 2N sodium hydroxide solution, 2N
aqueous hydrogen chloride and brine, dried over anhy-
drous sodium sulfate and evaporated, the crude
product was purified by column chromatography to
afford the alcohol 1 (390 mg, 89%), [h]2D0 +14.4 (c 5.5,
CHCl3, d.e.>91%).
1
CHCl3). H NMR l 1.450 (d, 3H, J=6.8 Hz), 2.398 (s,
3H), 3.077–3.250 (m, 1H), 3.469–3.665 (m, 2H), 7.186
(s, 4H). MS (EI): m/z 214, 212, 133, 119 and 91.
3.5. (7S,9R)-(+)-Bisacumol, 1 and (7S,9S)-(+)-bisacu-
mol, epi-1
Under an atmosphere of Ar, a solution of bromide 6
(2.0 g, 9.4 mmol) together with iodomethane (1.6 g,
11.3 mmol) in dry ethyl ether (30 mL) was added
dropwise to magnesium powder (600 mg, 25 mmol) in
dry ethyl ether (10 mL). The mixture was stirred under
reflux for 3 h, and then cooled to −20°C, 3-methyl
crotonaldehyde (2.0 g, 24 mmol) was added slowly, the
mixture was stirred at this temperature for 2 h, and rt
for another 2 h, then quenched with saturated ammo-
nium chloride. After separation of the organic layer, the
aqueous phase was further extracted with ethyl acetate
(3×50 mL), The combined organic extracts were dried
over anhydrous sodium sulfate and evaporated to give
a pair of diastereoisomers. This crude product was
purified by column chromatography to afford (7S,9R)-
(+)-bisacumol, 1 (0.68 g, 33%) and (7S,9S)-(+)-bisacu-
mol, epi-1 (0.72 g, 35%), respectively.
Acknowledgements
We are grateful to the National Science Foundation of
China (NO. 20172023) for financial support.
References
Data for compound 1: [h]2D0 +15.6 (c 8.4, CHCl3, lit.1
1. Uehara, S. I.; Yasuda, I.; Takeya, K.; Itokawa, H. Chem.
Pharm. Bull. 1989, 37, 237.
1
[h]D +13.9 (c 0.42, EtOH). H NMR l 1.293 (d, 3H,
J=7.1 Hz), 1.581 and 1.736 (s, each 3H), 1.690–1.760
(m, 1H), 1.838–1.922 (m, 1H), 2.385 (s, 3H), 2.916–
2.971 (m, 1H), 4.191 (ddd, 1H, J=8.4, 8.4, 5.0 Hz),
5.205 (dd, 1H, J=9.6, 1.3 Hz), 7.146 (s, 4H). 13C NMR
l 17.89, 20.61, 22.90, 25.51, 35.71, 45.83, 66.66, 126.79,
128.55, 128.91, 133.89, 135.11, 143.90. MS (EI): m/z
218, 203, 200, 185, 157, 119, 85.
2. (a) Fusetani, N.; Sugano, M.; Matsunaga, S.; Hashimoto,
K. Experientia 1987, 43, 1234; (b) Wright, A. E.;
Pomponi, S. A.; Mcconell, O. J.; Kohmoto, S.; Mccarthy,
P. J. J. Nat. Prod. 1987, 50, 976; (c) Itokawa, H.; Takeya,
K. Heterocycles 1993, 35, 1467.
3. (a) Graham, S. L.; Heathcock, C. H.; Pirrung, M. C.;
Plavac, F.; White, C. T. Total Synth. Nat. Prod. 1983, 5,
35; (b) Jazouli, M. E.; Masson, S.; Thuillier, A. J. Chem.
Soc., Chem. Commun. 1985, 1598; (c) Nagumo, S.; Irie,
S.; Hayashi, K.; Akita, H. Heterocycles 1996, 43, 1175;
(d) Ono, M.; Yamamoto, Y.; Akita, H. Chem. Pharm.
Bull. 1995, 43, 553.
4. (a) Asoka, N.; Shima, K.; Fuju, N.; Takei, H. Tetra-
hedron 1988, 44, 4757; (b) Takano, S.; Sugihara, T.;
Samizu, K.; Akiyama, M.; Ogasawara, K. Chem. Lett.
1989, 1781; (c) Takano, S.; Yanase, M.; Sugihara, T.;
Ogasawara, K. J. Chem. Soc., Chem. Commun. 1988,
1
Data for epi-1: [h]D20 +9.4 (c 9.7, CHCl3). H NMR l
1.292 (d, 3H, J=7.0 Hz), 1.579 and 1.782 (s, each 3H),
1.661–1.728 (m, 1H), 1.965–2.037 (m, 1H), 2.373 (s,
3H), 2.750–2.971 (m, 1H), 4.210–4.267 (m, 1H), 5.192
(dd, 1H, J=9.0, 1.4 Hz), 7.113 (d, 2H, J=8.4 Hz),
7.142 (d, 2H, J=8.4 Hz). 13C NMR l 18.10, 20.62,
22.79, 25.65, 35.93, 45.92, 66.69, 126.72, 128.07, 128.92,
1335.08, 135.16, 144.03. MS (EI): m/z 218, 203, 185,
157, 119, 85.